Company Directory / Biotechnology

PrivateFor profitBiotechnologySan Diego, CA, United States
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead product, DAS181, is a multi-function sialidase fusion protein for host-cellprotection in respiratory virus infection, including parainfluenza, influenza and COVID19,. We are also advancing several additional programs in oncology and autoimmune diseases using our sialidase platform technology.
Size
11-50 people: larger than 33% of companies with a size listed. 22 people list it on LinkedIn.
Age
23 years old.
Reach
Website ranked #15,479,452 in the world for traffic, about 3 visits a month. 2,066 followers on LinkedIn.
BiopharmaBiotechnologyClinical TrialsHealth CareMedical
Funding, as listed
$213M raised in total
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Ansun BioPharma, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Biotechnology in United States.
InsmedBridgewater Township · 501-1000 people · 51k followersSSAGE TherapeuticsCambridge · 501-1000 people · 111k followers
InvitaeSan Francisco · 1001-5000 people · 146k followers
Amicus TherapeuticsPrinceton · 501-1000 people · 48k followers
GrailMenlo Park · 1001-5000 peopleFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.